本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tarsus Pharmaceuticals, Inc.

67.20
+0.24000.36%
盘后67.200.00000.00%16:22 EDT
成交量:68.98万
成交额:4,665.06万
市值:28.53亿
市盈率:-42.26
高:68.77
开:66.32
低:65.95
收:66.96
52周最高:85.25
52周最低:38.51
股本:4,244.91万
流通股本:3,035.16万
量比:1.32
换手率:2.27%
股息:- -
股息率:- -
每股收益(TTM):-1.5900
每股收益(LYR):-1.5900
净资产收益率:-23.39%
总资产收益率:-9.45%
市净率:8.31
市盈率(LYR):-42.26

数据加载中...

2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/23

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/23

重要事件披露

Form 8-K - Current report
2026/02/18

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/04

重要事件披露

Form 8-K - Current report
2025/09/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/09/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities